Shacham Sharon
SEC insider (Form 3/4/5 filer). CIK 0001588438. Director at Acrivon Therapeutics, Inc. (ACRV) and 1 other issuer. 3 reported Form 4/5 transactions since Sep 2024; latest on Jun 17, 2026. Located in WATERTOWN, MA.
Companies Shacham Sharon has filed insider reports for
- Acrivon Therapeutics, Inc. (ACRV): Director
- Nasus Pharma Ltd (NSRX): Director
Shacham Sharon
CIK: 0001588438
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Jun 17, 2026ACRV
Acrivon Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
20.3K shares- - May 18, 2026ACRV
Acrivon Therapeutics, Inc.
AwardDirect9.4K shares- - Jun 13, 2025ACRV
Acrivon Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
20.3K shares-
1-3 of 3 transactions